Literature DB >> 22692670

Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.

Konstantinos Michalakis1, Carel le Roux.   

Abstract

Obesity is now considered the new world epidemic. In an attempt to face this menace to public health, several treatments, apart from the traditional nutritional modification and oral medication, have been introduced, among them bariatric surgery and gut hormone-based treatments. The gastrointestinal (GI) tract is a powerful endocrine organ, releasing active peptides and influencing appetite and glycaemic control. Alteration of the GI tract, in ways that exaggerate the secretion and levels of the gut hormones, creates a new functional equilibrium that further contributes to weight loss. The purpose of this review is to explore the mechanisms that drive this gut hormone-derived body regulation, as well as the changes that occur to them after bariatric surgery. Close to that, leptin, a hormone secreted by adipose tissue will be analysed, as its pathways are closely related to those of the gut hormones. Gut hormones are strongly implicated in energy control, and various effects of bariatric surgery in weight loss are directly related to the alteration of the levels of these hormones.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22692670     DOI: 10.1007/s11695-012-0698-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  97 in total

1.  Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study.

Authors:  Ole-Petter R Hamnvik; Xiaowen Liu; Michael Petrou; Huizhi Gong; John P Chamberland; Esther H Kim; Costas A Christophi; Stefanos N Kales; David C Christiani; Christos S Mantzoros
Journal:  Metabolism       Date:  2010-11-05       Impact factor: 8.694

2.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

4.  Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men.

Authors:  M S Westerterp-Plantenga; W H Saris; C J Hukshorn; L A Campfield
Journal:  Am J Clin Nutr       Date:  2001-10       Impact factor: 7.045

5.  Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.

Authors:  Kevin B Barker; Nicole A Palekar; Steven P Bowers; Joel E Goldberg; Joseph P Pulcini; Stephen A Harrison
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

6.  DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.

Authors:  John B Buse; Daniel J Drucker; Kristin L Taylor; Terri Kim; Brandon Walsh; Hao Hu; Ken Wilhelm; Michael Trautmann; Larry Z Shen; Lisa E Porter
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 19.112

7.  Long-term results of bariatric restrictive procedures: a prospective study.

Authors:  Ruben Schouten; Dorothee C Wiryasaputra; Francois M H van Dielen; Wim G van Gemert; Jan Willem M Greve
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

8.  Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

Authors:  Catherine L Dakin; Caroline J Small; Rachel L Batterham; Nicola M Neary; Mark A Cohen; Michael Patterson; Mohammad A Ghatei; Stephen R Bloom
Journal:  Endocrinology       Date:  2004-03-04       Impact factor: 4.736

9.  Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.

Authors:  Ronald H Clements; Quintin H Gonzalez; Calvin I Long; Gary Wittert; Henry L Laws
Journal:  Am Surg       Date:  2004-01       Impact factor: 0.688

10.  Inhibition of gastric inhibitory polypeptide signaling prevents obesity.

Authors:  Kazumasa Miyawaki; Yuichiro Yamada; Nobuhiro Ban; Yu Ihara; Katsushi Tsukiyama; Heying Zhou; Shimpei Fujimoto; Akira Oku; Kinsuke Tsuda; Shinya Toyokuni; Hiroshi Hiai; Wataru Mizunoya; Tohru Fushiki; Jens Juul Holst; Mitsuhiro Makino; Akira Tashita; Yukari Kobara; Yoshiharu Tsubamoto; Takayoshi Jinnouchi; Takahito Jomori; Yutaka Seino
Journal:  Nat Med       Date:  2002-06-17       Impact factor: 53.440

View more
  19 in total

Review 1.  Role of gastrointestinal hormones in feeding behavior and obesity treatment.

Authors:  Timothy Sean Kairupan; Haruka Amitani; Kai-Chun Cheng; Joshua Runtuwene; Akihiro Asakawa; Akio Inui
Journal:  J Gastroenterol       Date:  2015-09-07       Impact factor: 7.527

2.  Reply to the article Espinós JC, Turró R, Mata A, Cruz M, da Costa M, Villa V, Buchwald JN, Turró J. Early experience with the Incision less Operating Platform™ (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg. 2013;23:1375-83.

Authors:  Ramon Vilallonga; Jacques Himpens
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

Review 3.  Changes in Resting Energy Expenditure in Relation to Body Weight and Composition Following Gastric Restriction: A Systematic Review.

Authors:  Matthew G Browning; Robert L Franco; John C Cyrus; Francesco Celi; Ronald K Evans
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

4.  Post-prandial anorexigenic gut peptide, appetite and glucometabolic responses at different eating rates in obese patients undergoing laparoscopic sleeve gastrectomy.

Authors:  Antonello Emilio Rigamonti; Silvia Bini; Maria Cristina Rocco; Vittorio Giardini; Diego Massimini; Maria Grazia Crippa; Antonella Saluzzi; Marco Casati; Nicoletta Marazzi; Mario Perotti; Vincenzo Cimino; Guido Grassi; Alessandro Sartorio; Angela Ida Pincelli
Journal:  Endocrine       Date:  2016-03-29       Impact factor: 3.633

5.  The One and Only Variable That Needs Statistical Significance: Human Quality.

Authors:  Konstantinos Michalakis
Journal:  Obes Surg       Date:  2020-06-03       Impact factor: 4.129

6.  Reduction of intestinal electrogenic glucose absorption after duodenojejunal bypass in a mouse model.

Authors:  Sheng Yan; Fei Sun; Zhiwei Li; Jie Xiang; Yuan Ding; Zhongjie Lu; Yang Tian; Hui Chen; Jinhua Zhang; Yan Wang; Penghong Song; Lin Zhou; Shusen Zheng
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

7.  Significant weight loss and rapid resolution of diabetes and dyslipidemia during short-term follow-up after laparoscopic sleeve gastrectomy.

Authors:  A Perathoner; A Weißenbacher; R Sucher; E Laimer; J Pratschke; R Mittermair
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

Review 8.  Peripheral mechanisms in appetite regulation.

Authors:  Michael Camilleri
Journal:  Gastroenterology       Date:  2014-09-21       Impact factor: 22.682

9.  Bone loss after bariatric surgery: causes, consequences, and management.

Authors:  Emily M Stein; Shonni J Silverberg
Journal:  Lancet Diabetes Endocrinol       Date:  2014-02-03       Impact factor: 32.069

10.  Reported nutrient intake over 7 years after Roux-en-Y gastric bypass in the Longitudinal Assessment of Bariatric Surgery-3 (LABS-3) psychosocial study.

Authors:  Susan K Raatz; LuAnn K Johnson; Alicia Caliquary; Wendy C King; Melissa A Kalarchian; Michael J Devlin; Marsha D Marcus; James E Mitchell
Journal:  Surg Obes Relat Dis       Date:  2020-04-22       Impact factor: 4.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.